Clinical Trial Update: Rituximab Versus Steroids and Cyclophosphamide in the Treatment of Idiopathic Membranous Nephropathy [Phase 3]

View source ↗

Summary

A phase 3 trial comparing rituximab to steroids and cyclophosphamide for idiopathic membranous nephropathy is being conducted, with status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glomerulonephritis
• Membranous Nephropathy

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | Conditions: Glomerulonephritis, Membranous | Phase 3 | Status: UNKNOWN